BSE filing, NSE: GODAVARI. Summary written from the filing by ALFA Finder's alert engine.
Godavari Drugs Ltd: key numbers
- Share price
- ₹119.70
- Market cap
- ₹121.2 Cr
- Revenue (annual)
- ₹105.8 Cr
- Net profit (annual)
- ₹4.09 Cr
- P/E (TTM)
- 29.1×Sector 43.0×
- Promoter holding
- 44.54%+4.31% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Godavari Drugs Ltd
All →Godavari Drugs Board Meeting Date
Godavari Drugs will hold a board meeting on 11 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. The trading window stays closed until 48 hours after the results are declared.
Godavari Drugs Convertible Warrants
Godavari Drugs allotted 7,86,690 equity shares to promoter-category allottees on conversion of warrants. The balance consideration of Rs 5.25 Crore was received at an issue price of Rs 89.
- Value
- ₹5.25 Cr
Godavari Drugs Other Announcement
Godavari Drugs filed its quarterly shareholding pattern for the period ended 30 September 2026. The filing is a routine Regulation 31 disclosure with no transaction.
Godavari Drugs Other Announcement
Godavari Drugs Limited changed its Corporate Identification Number (CIN) following an alteration to its Memorandum of Association's Object Clause. The Ministry of Corporate Affairs registered the change on October 16, 2026.
Godavari Drugs Debt & Borrowing: ₹34 Cr
Godavari Drugs Limited's board approved availing working capital limits of Rs. 34 Crore from ICICI Bank. The facility is within existing shareholder-approved borrowing limits.
- Value
- ₹34.00 Cr
Godavari Drugs Annual General Meeting
Godavari Drugs held its 38th Annual General Meeting on September 25, 2026, via video conferencing. Shareholders approved financial statements, director re-appointment, and object clause alteration.
Other board meeting date announcements
All →TechNVision Ventures Board Meeting Date
TechNVision Ventures intimates a board meeting on 13 November 2026 to approve unaudited results for Q2 and H1 ended 30 September 2026. Trading window has been closed since 1 October 2026.
Reliance Infrastructure Board Meeting Date
Reliance Infrastructure will hold a board meeting on 13 November 2026 to consider unaudited results and long-term fundraising. Agenda items remain proposed until the meeting is held.
Mini Diamonds (India) Board Meeting Date
Mini Diamonds India will hold a board meeting on 14 November 2026 to consider unaudited standalone and consolidated results for the quarter and half-year ended September 2026. The trading window stays closed until 48 hours after the results are declared.
KMF Builders & Developers Board Meeting Date
KMF Builders will meet on 14 November 2026 to consider unaudited standalone results for Q2 2026. The trading window stays closed until results are announced.
The Fertilisers and Chemicals Travancore Board Meeting Date
Fertilizers and Chemicals Travancore will hold a board meeting on 13 November 2026 to consider September 2026 quarter results. No monetary event is disclosed.
Anuroop Packaging Board Meeting Date
Anuroop Packaging will hold a board meeting on 14 November 2026 to consider September 2026 quarter results. No monetary event is disclosed.